These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6016858)
21. Cutaneous and ocular changes associated with the use of chlorpromazine. Wolf ME; Richer S; Berk MA; Mosnaim AD Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679 [TBL] [Abstract][Full Text] [Related]
22. [Eye and skin complications with long-term treatment of psychopharmaceutic agents]. Gunby B Nord Psykiatr Tidsskr; 1967; 21(5):378-88. PubMed ID: 5587721 [No Abstract] [Full Text] [Related]
23. Ocular melanosis with special reference to chlorpromazine. Cameron ME Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771 [No Abstract] [Full Text] [Related]
25. [Damage to eyes through conservative therapy]. Kleberger E Klin Monbl Augenheilkd; 1967; 151(6):777-801. PubMed ID: 4874408 [No Abstract] [Full Text] [Related]
26. In vivo observations of a case of chlorpromazine deposits in the cornea using an HRT II Rostock corneal module. Toshida H; Uesugi Y; Ebihara N; Murakami A Cornea; 2007 Oct; 26(9):1141-3. PubMed ID: 17893554 [TBL] [Abstract][Full Text] [Related]
27. Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series. Gowda GS; Hegde A; Shanbhag V; Narayanaswamy JC; Jaisoorya TS Asian J Psychiatr; 2017 Feb; 25():188-190. PubMed ID: 28262147 [TBL] [Abstract][Full Text] [Related]
28. Ocular changes produced by chlorpromazine. Dencker SJ; Enoksson P Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234 [No Abstract] [Full Text] [Related]
29. Toxic effects of phenothiazines on the eye. Boet DJ Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274 [No Abstract] [Full Text] [Related]
30. [False-positive ocular pigmentation during administration of neuroleptics]. Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2575-6. PubMed ID: 4945027 [No Abstract] [Full Text] [Related]
31. Ocular changes associated with chlorpromazine therapy. A preliminary report. Edler K Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235 [No Abstract] [Full Text] [Related]
32. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. GREINER AC; BERRY K Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375 [TBL] [Abstract][Full Text] [Related]
33. [Ocular complications in chronic psychiatric patients caused by prolonged use of antipsychotic drugs (author's transl)]. Yang Y Zhonghua Yan Ke Za Zhi; 1979; 15(3):198-200. PubMed ID: 45367 [No Abstract] [Full Text] [Related]
34. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine. Gualtieri CT; Lefler WH; Guimond M; Staye JI Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312 [TBL] [Abstract][Full Text] [Related]
35. [Ultrastructural study of corneal thickening in the course of chlorpromazine treatment]. Pouliquen Y; Graf B; Bisson J; Feuvrier YM; Delattre A Arch Ophtalmol Rev Gen Ophtalmol; 1970 Nov; 30(11):769-82. PubMed ID: 4250388 [No Abstract] [Full Text] [Related]
36. [Ocular changes in long-term treatment with Largactil]. Kalberer M; Atar Z; Bider E Ophthalmologica; 1970; 161(2):118-24. PubMed ID: 4989755 [No Abstract] [Full Text] [Related]